The biggest risk factors include: Baseline MAFLD diagnosis (aHR 2.11) BMI between 30-34 compared to BMI 40+ (aHR 1.93) Pre-existing GERD (aHR 1.80) Female gender (aHR 1.56) [4] Different GLP-1 medications show varying risk levels
demonstrated that intentional weight loss significantly improved the response of obese PsO patients to low-dose cyclosporine ( Collectively, these data highlight the importance of integrating metabolic health into early therapeutic strategies for PsA, particularly in individuals at high risk of disease progression or in those presenting with subclinical musculoskeletal involvement
Research in animal models indicates that GLP-1 receptor agonists reduce self-administration of cocaine, nicotine, and alcohol by modulating dopamine signaling (Egecioglu et al., 2013
The Inferto-Sex Syndrome (ISS): sexual dysfunction in fertility care setting and assisted reproduction
Physiological Reviews, 2007
Ozempic (semaglutide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus in adults